MLchartDataset catalogue

epidiferphane

Term · Oncology and biomedicine · MLC-T-ONC-013385

An orally bioavailable, proprietary botanical-based formulation and nutritional supplement consisting of three botanical extracts, including broccoli powder and curcumin, that may be used to reduce taxane-induced side effects and toxicities. Upon oral administration, epidiferphane may be able to decrease inflammation and pain by reducing cytokine levels. It may also reduce taxane-mediated toxicities such as anemia, neutropenia, peripheral neuropathy, and protect the endogenous neural stem cell population against destruction thereby preventing memory problems associated with the loss of neural stem cells.

Table 1. Record
IdentifierMLC-T-ONC-013385
FieldOncology and biomedicine
AbbreviationEDP
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013385",
  "term": "epidiferphane",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable, proprietary botanical-based formulation and nutritional supplement consisting of three botanical extracts, including broccoli powder and curcumin, that may be used to reduce taxane-induced side effects and toxicities. Upon oral administration, epidiferphane may be able to decrease inflammation and pain by reducing cytokine levels. It may also reduce taxane-mediated toxicities such as anemia, neutropenia, peripheral neuropathy, and protect the endogenous neural stem cell population against destruction thereby preventing memory problems associated with the loss of neural stem cells.",
  "abbreviation": "EDP",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/epidiferphane/"
}

Record 6,768 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.